Cargando…
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
SIMPLE SUMMARY: T cells that are genetically engineered to express chimeric antigen receptors constitute an effective new therapy with curative potential for patients with hematological tumors. The value of chimeric antigen receptor T cells in childhood brain tumors, the leading cause of cancer deat...
Autores principales: | Thomas, Pauline, Galopin, Natacha, Bonérandi, Emma, Clémenceau, Béatrice, Fougeray, Sophie, Birklé, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582542/ https://www.ncbi.nlm.nih.gov/pubmed/34771608 http://dx.doi.org/10.3390/cancers13215445 |
Ejemplares similares
-
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
por: Fleurence, Julien, et al.
Publicado: (2017) -
CAR T Cell Therapy for Pediatric Brain Tumors
por: Patterson, John D., et al.
Publicado: (2020) -
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016) -
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
por: Alvarez-Rueda, Nidia, et al.
Publicado: (2011) -
Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid Tumors
por: Alcantara, Marion, et al.
Publicado: (2020)